A |
2025-02-19 |
|
Werewolf Therapeutics, Inc. |
4 |
A-Award |
--D |
45000.0000 |
45000.0000 |
1 |
0001785530 |
Stock Option (right to buy) |
A |
2024-08-13 |
|
TriSalus Life Sciences, Inc. |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0001826667 |
Director stock option (right to buy) |
A |
2023-08-10 |
|
TriSalus Life Sciences, Inc. |
4 |
A-Award |
--D |
35000.0000 |
35000.0000 |
1 |
0001826667 |
Stock Option (right to buy) |
- |
- |
|
TriSalus Life Sciences, Inc. |
3 |
- |
--D |
|
|
1 |
0001826667 |
Stock Option (right to buy) |
- |
- |
|
TriSalus Life Sciences, Inc. |
3 |
- |
--D |
|
|
2 |
0001826667 |
Stock Option (right to buy) |
- |
- |
|
TriSalus Life Sciences, Inc. |
3 |
- |
--D |
|
|
3 |
0001826667 |
Stock Option (right to buy) |
- |
- |
|
TriSalus Life Sciences, Inc. |
3 |
- |
--D |
|
|
4 |
0001826667 |
Stock Option (right to buy) |
- |
- |
|
Werewolf Therapeutics, Inc. |
3 |
- |
--- |
|
|
1 |
- |
- |